VanEck Pharmaceutical ETF Rating $86.15 +0.87 (+1.02%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$86.16 +0.00 (+0.01%) As of 08/14/2025 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.59Holdings in PPH have an aggregate rating of Moderate Buy based on 267 analyst ratings issued in the past year covering 22 companies (92.6% of the portfolio).PPH Aggregate Price Target$86.15High Prediction$86.15Average Prediction$86.15Low Prediction$86.15Holdings in PPH have an aggregate price target of $86.15 and a range of $86.15 to $86.15 covering 22 companies (92.6% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings18.81%LLYEli Lilly and Company$685.27+3.8%4.9993 of 5 stars2.65$964.88 40.8%20Trending NewsAnalyst ForecastInsider TradeOptions Volume10.92%JNJJohnson & Johnson$174.96+0.3%4.8448 of 5 stars2.65$174.50 -0.3%20Positive News7.60%NVONovo Nordisk A/S$50.92+0.0%4.6727 of 5 stars2.07$83.75 64.5%14Trending NewsAnalyst Upgrade6.10%MRKMerck & Co., Inc.$82.77+0.1%4.9972 of 5 stars2.35$107.44 29.8%20Positive News4.70%PFEPfizer$25.12-0.2%4.9633 of 5 stars2.39$28.12 12.0%18Trending News4.58%SNYSanofi$49.04+0.6%4.3603 of 5 stars3.11$62.00 26.4%94.54%AZNAstraZeneca$78.47+0.7%2.958 of 5 stars2.80$86.00 9.6%5Positive NewsAnalyst Revision4.52%ABBVAbbVie$204.78+1.6%4.7368 of 5 stars2.93$214.95 5.0%27Trending NewsAnalyst ForecastInsider Trade4.49%MCKMcKesson$674.53+1.7%4.507 of 5 stars2.86$719.27 6.6%14Positive NewsAnalyst Forecast4.43%BMYBristol Myers Squibb$47.86+0.0%4.7867 of 5 stars2.24$56.38 17.8%21Trending NewsAnalyst Revision4.17%GSKGSK$39.20+0.2%2.6799 of 5 stars1.88$37.38 -4.6%84.17%ZTSZoetis$153.16+0.5%4.9247 of 5 stars2.50$202.43 32.2%8Positive News3.69%CORCencora$295.20+1.4%4.3161 of 5 stars2.75$311.25 5.4%12Positive NewsAnalyst Forecast3.41%HLNHaleon$9.71+0.2%4.3058 of 5 stars2.78$12.33 27.0%9News CoveragePositive News2.77%TAKTakeda Pharmaceutical$14.80+0.2%1.4858 of 5 stars3.001Short Interest ↑1.52%TEVATeva Pharmaceutical Industries$17.55+2.0%3.7187 of 5 stars3.25$24.71 40.8%80.67%VTRSViatris$10.69+2.7%2.223 of 5 stars1.80$10.40 -2.7%5Insider Trade0.51%JAZZJazz Pharmaceuticals$116.67-0.4%4.4374 of 5 stars2.93$181.43 55.5%14Positive News0.34%ELANElanco Animal Health$17.99+1.0%2.904 of 5 stars2.88$17.33 -3.7%80.28%AXSMAxsome Therapeutics$108.75-0.6%4.7325 of 5 stars3.07$178.00 63.7%150.21%PRGOPerrigo$23.04-2.6%4.8765 of 5 stars2.40$33.00 43.2%50.17%OGNOrganon & Co.$9.39+0.3%4.6966 of 5 stars2.50$18.00 91.8%6 This page (NASDAQ:PPH) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access